Rose Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Antiperspirant OTC Labeling Flexibility Requested By CTFA

Executive Summary

Antiperspirant labeling should be allowed to drop the "Drug Facts" heading required for OTCs because it "is unnecessary and reduces the space available for important label information," the Cosmetic, Toiletry and Fragrance Association states in an April 11 citizen petition to FDA
Advertisement

Related Content

Antiperspirant Labeling Determined Appropriate In FDA Petition Denial
Antiperspirant Labeling Determined Appropriate In FDA Petition Denial
Cosmetic-Drug Products Subject To FDA's OTC Labeling Final Rule
Advertisement
UsernamePublicRestriction

Register

RS010211

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel